Labetalol pharmacokinetics in pregnancy-induced hypertension
- 1 February 1990
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 162 (2) , 362-366
- https://doi.org/10.1016/0002-9378(90)90386-l
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Rising Multiple‐Dose Pharmacokinetics of Labetalol in Hypertensive PatientsThe Journal of Clinical Pharmacology, 1986
- Labetalol for the Treatment of Hypertension in Pregnancy: Pharmakokinetics and effects on the uteroplacental blood flowActa Obstetricia et Gynecologica Scandinavica, 1984
- Labetalol disposition and concentration-effect relationships during pregnancy.British Journal of Clinical Pharmacology, 1983
- The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol.British Journal of Clinical Pharmacology, 1982
- The evaluation of labetalol in the treatment of hypertension complicating pregnancy.Published by Wiley ,1982
- Elimination kinetics of labetalol in severe renal failure.British Journal of Clinical Pharmacology, 1982
- Use of labetalol in the treatment of severe hypertension during pregnancy.British Journal of Clinical Pharmacology, 1979
- Use of labetalol and methyldopa in pregnancy‐induced hypertension.British Journal of Clinical Pharmacology, 1979
- Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects.Published by Wiley ,1979
- Food, splanchnic blood flow, and bioavailability of drugs subject to first‐pass metabolismClinical Pharmacology & Therapeutics, 1978